EVANS GARY C

SEC source: 0001104659-26-103384 · tm2624326-1_4seq1.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,590,028

SEC source: 0001104659-26-035834 · tm2610082-1_4seq1.xml · nonDerivative · entry 4

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,231,951

SEC source: 0001104659-26-035834 · tm2610082-1_4seq1.xml · nonDerivative · entry 3

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,331,951

SEC source: 0001104659-26-035834 · tm2610082-1_4seq1.xml · nonDerivative · entry 2

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,431,951

SEC source: 0001104659-26-035834 · tm2610082-1_4seq1.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,531,951

SEC source: 0001104659-26-036636 · tm2610602-1_4seq1.xml · derivative · entry 2

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 308,133 shares

Expires not disclosed

F2 · security: Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

F2 · shares: Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

F2 · price: Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.exercise_date: Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.expiration_date: Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

F2 · balance_after: Represents shares of Common Stock underlying a stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date.

SEC source: 0001104659-26-036636 · tm2610602-1_4seq1.xml · derivative · entry 1

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 304,524 shares

Expires not disclosed

F1 · security: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 101,508 shares of the 304,524 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

F1 · shares: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 101,508 shares of the 304,524 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

F1 · price: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 101,508 shares of the 304,524 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

F1 · derivative.exercise_date: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 101,508 shares of the 304,524 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

F1 · derivative.expiration_date: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 101,508 shares of the 304,524 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

F1 · balance_after: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 101,508 shares of the 304,524 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

SEC source: 0001654954-25-011268 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,378,818

SEC source: 0001654954-25-011256 · section16.xml · derivative · entry 2

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 750,000 shares

Expires not disclosed

F2 · security: Represents shares of Common Stock underlying a stock option award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F2 · shares: Represents shares of Common Stock underlying a stock option award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F2 · price: Represents shares of Common Stock underlying a stock option award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F2 · derivative.exercise_date: Represents shares of Common Stock underlying a stock option award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F2 · derivative.expiration_date: Represents shares of Common Stock underlying a stock option award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F2 · balance_after: Represents shares of Common Stock underlying a stock option award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended Restated 2023 Equity Incentive Plan. The stock option will vest upon meeting any of the performance measures specified in the grant at any time during the 10-year term of the award, subject to the Reporting Person's continued service through any vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

SEC source: 0001654954-25-011256 · section16.xml · derivative · entry 1

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 750,000 shares

Expires not disclosed

F1 · security: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended and Restated 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F1 · shares: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended and Restated 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F1 · price: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended and Restated 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F1 · derivative.exercise_date: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended and Restated 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F1 · derivative.expiration_date: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended and Restated 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

F1 · balance_after: Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on May 27, 2025, but contingent on the Issuer's shareholders approving its Amended and Restated 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on May 27, 2025 and an additional one-third of the total number of shares will vest on May 27, 2026 and May 27, 2027, subject to the Reporting Person's continued service through each vesting date and shareholder approval of the Issuer's Amended Restated 2023 Equity Incentive Plan.

SEC source: 0001654954-24-015418 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,528,818

SEC source: 0001654954-24-006790 · section16.xml · derivative · entry 2

EVANS GARY C · CIK 0001191410 · Director · Chairman & Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 750,000 shares

Expires not disclosed

F2 · security: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 250,000 shares of the 750,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · shares: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 250,000 shares of the 750,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · price: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 250,000 shares of the 750,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.exercise_date: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 250,000 shares of the 750,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · derivative.expiration_date: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 250,000 shares of the 750,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

F2 · balance_after: Represents shares of Common Stock underlying a stock option award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 250,000 shares of the 750,000 total number of shares on March 1, 2025 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through any vesting date.

SEC source: 0001654954-24-006790 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director · Chairman & Co-CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,326,050

F1 · security: Represents shares of Common Stock underlying a restricted stock unit ("RSU") award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on March 1, 2024 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

F1 · shares: Represents shares of Common Stock underlying a restricted stock unit ("RSU") award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on March 1, 2024 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

F1 · price: Represents shares of Common Stock underlying a restricted stock unit ("RSU") award granted on March 1, 2024 under the Issuer's 2023 Equity Incentive Plan. One-third, or 250,000 shares of the 750,000 total number of shares, of the RSU award vested on March 1, 2024 and an additional one-third of the total number of shares on each annual anniversary thereafter, subject to the Reporting Person's continued service through each vesting date.

SEC source: 0001654954-23-000631 · section16.xml · nonDerivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 956,849

SEC source: 0001654954-23-000631 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 935,781

SEC source: 0001654954-23-000454 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 935,481

SEC source: 0001654954-23-000455 · section16.xml · nonDerivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 904,112

SEC source: 0001654954-23-000455 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 883,168

SEC source: 0001654954-22-016791 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 864,032

SEC source: 0001654954-22-016631 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 835,239

SEC source: 0001654954-22-016576 · section16.xml · nonDerivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 716,038

SEC source: 0001654954-22-016576 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 647,048

SEC source: 0001654954-22-016791 · section16.xml · nonDerivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 878,031

SEC source: 0001654954-22-016363 · section16.xml · nonDerivative · entry 3

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408,836

SEC source: 0001654954-22-016363 · section16.xml · nonDerivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,934

SEC source: 0001654954-22-016363 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 291,281

SEC source: 0001654954-22-016305 · section16.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

SEC source: 0001209191-21-042444 · doc4.xml · derivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,450 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

F2 · derivative.exercise_date: In connection with the reporting person's departure from the Board of Directors (the "Board"), the Board accelerated the vesting of 3,450 restricted stock units subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), to June 17, 2021 from June 25, 2021.

F2 · derivative.expiration_date: In connection with the reporting person's departure from the Board of Directors (the "Board"), the Board accelerated the vesting of 3,450 restricted stock units subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), to June 17, 2021 from June 25, 2021.

SEC source: 0001209191-21-042444 · doc4.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,549

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock.

SEC source: 0001209191-21-037803 · doc4.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Evans 1997 Trust

Disclosed balance after: 0

SEC source: 0001209191-21-021528 · doc4.xml · derivative · entry 9

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,000 shares

Expires 2029-12-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Plan vested one (1) year from the December 12, 2019 grant date.

SEC source: 0001209191-21-021528 · doc4.xml · derivative · entry 8

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,500 shares

Expires 2028-12-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Plan vested one (1) year from the December 13, 2018 grant date.

SEC source: 0001209191-21-021528 · doc4.xml · derivative · entry 7

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,000 shares

Expires 2026-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan") vested six (6) months from the March 15, 2016 grant date.

SEC source: 0001209191-21-021528 · doc4.xml · nonDerivative · entry 5

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,099

SEC source: 0001209191-21-021528 · doc4.xml · nonDerivative · entry 4

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,867

SEC source: 0001209191-21-021528 · doc4.xml · nonDerivative · entry 3

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-021528 · doc4.xml · nonDerivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-021528 · doc4.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,099

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000584 · edgar.xml · derivative · entry 10

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2027-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000584 · edgar.xml · derivative · entry 9

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,000 shares

Expires 2027-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000584 · edgar.xml · derivative · entry 8

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,500 shares

Expires 2023-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000584 · edgar.xml · derivative · entry 7

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,000 shares

Expires 2021-03-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000584 · edgar.xml · nonDerivative · entry 5

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 321,979

F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.3125 to $151.06, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.

SEC source: 0000904454-20-000584 · edgar.xml · nonDerivative · entry 4

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 332,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000584 · edgar.xml · nonDerivative · entry 3

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000584 · edgar.xml · nonDerivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 324,479

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000904454-20-000584 · edgar.xml · nonDerivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 322,979

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-20-039193 · doc4.xml · derivative · entry 2

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,450

Underlying: Common Stock · 3,450 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date.

F3 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to this grant under the Plan, will vest one (1) year from the Grant Date, subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001209191-20-039193 · doc4.xml · derivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,900

Underlying: Common Stock · 6,900 shares

Expires 2030-06-25

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest one (1) year from the June 25, 2020 grant date (the "Grant Date"), subject to continued service on the Company's Board of Directors through the vesting date.

SEC source: 0001209191-19-060688 · doc4.xml · derivative · entry 1

EVANS GARY C · CIK 0001191410 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Stock · 18,000 shares

Expires 2029-12-12

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended, will vest one (1) year from the December 12, 2019 grant date subject to continued service on the Company's Board of Directors through the vesting date.